Work

Abstract PD13-09: A Real-World Multicenter Study in China: Efficacy and Safety of Sacituzumab Govitecan in Heavily Pretreated HER2-Negative Metastatic Breast Cancer Patients and Brain Metastases

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-pd13-09

Authors: X. Liang, S. Guohong, P. Yong, L. Zhijun, L. Huiping

Institutions: Peking University Cancer Hospital, Beijing Luhe Hospital Affiliated to Capital Medical University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129549660

Cites:

Cited by:

Related to: